Roivant Sciences Ltd. (ROIV) Tops Q3 EPS by 48c

Roivant Sciences Ltd. (NASDAQ: ROIV) reported Q3 EPS of $0.23, $0.48 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $9.02 million versus the consensus estimate of $8.14 million.

For earnings history and earnings-related data on Roivant Sciences Ltd. (ROIV) click here.

You May Also Be Interested In

• Anthropic Signs $35b Cloud Deal With Lambda In Texas: WSJ
• Ares closes Japan logistics fund at ¥612 billion hard cap
• Lobe Sciences closes $2.16M private placement for S-100 drug program